The AngioSculpt PTA scoring balloon catheter in 7 and 8 millimeter diameter balloon sizes are ideally suited to treat the narrowing of the native or synthetic fistula. The product assists physicians with a difficult patient set, targeting lesions in the hemodialysis access that are resistant to standard balloon angioplasty.
Precision: Minimal slippage
Rectangular scoring edges lock the device in place. No significant device slippage or “watermelon seeding” means less risk of damage to healthy tissue.
Power: More dilitation force
The leading edges are designed to drive outward expansion with up to ~15-25 times the force of a conventional balloon.³ AngioSculpt’s helical nitinol element creates a uniform initial luminal enlargement
Safety: Low dissection rate
Post scoring, outward forces are designed to be equivalent to that of a conventional balloon resulting in a low dissection rate and minimal perforations, along with a low rate of adjunctive stenting.
Resistant stenoses
Lesions resistant to PTA are common and as many as 20% will require a high pressure dilatation (greater than 20 atm)
Recoil
Recoil and neointimal proliferation frequently lead to recurrent access dysfunction within several months of the angioplasty procedure
Recurrent stenoses
~50% of all patients who undergo PTA will return with recurrent stenoses within 6 months